ContextVision - Second quarter saw commercial release of first AI-based product, AltumiraTM, Digital Pathology on ...
(WorldNews Sweden)

STOCKHOLM - August 15, 2019 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, continued to advance its artificial intelligence portfolio in the second quarter 2019. The company´s AI-based product AltumiraTM for X-ray is now commercially available and INIFY Prostate for digital pathology will soon move to beta testing in several pathology labs. Q2 sales reached 23,1 MSEK, record sales for second quarter, 5,5% higher than Q2 2018. The operating result was positive 5,4 MSEK, mainly due to higher capitalization for product development but also supported by strong sales performance. ......